ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults

RECOMMENDED

Pneumonia

Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, Musher DM, Erstad BL, Pickens C, Vaughn VM, Helgeson SA, Crothers K, Metlay JP, Bissell B, Cao B, Chalmers JD, Dela Cruz CS, Gendlina I, Hojat LS, Laguio-Vila M, Liang SY, Waterer GW, Paine M, Hawkins C, Wilson K

doi: 10.1164/rccm.202507-1692ST

RECOMMENDED

Pneumonia

The Long-term Pneumonia Mortality Index. An International Multicenter Derivation and Validation Study for Patients with Community-Acquired Pneumonia

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Méndez R, González-Jiménez P, Latorre A, Piqueras M, Mengot N, Hervás D, Knox D, Carr J, Barten-Neiner G, Rohde G, Pletz MW, Rupp J, Witzenrath M, Dean NC, Menéndez R

doi: 10.1093/ajrccm/aamag060

RECOMMENDED

Sleep Apnea

Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

J Clin Sleep Med

Mehra R, Auckley DH, Johnson KG, Billings ME, Carandang G, Khayat RN, Pena-Orbea C, Sahni AS, Sharma S, Patil SP

doi: 10.5664/jcsm.11864

COMMENTED

Pneumonia

Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Eur Respir J

Ryerson CJ, Adegunsoye A, Piciucchi S, Hariri LP, Khor YH, Wijsenbeek MS, Wells AU, Sharma A, Cooper WA, Antoniou K, Borie R, Fabre A, Inoue Y, Johannson K, Johkoh T, Kawana-Dourado L, Kazerooni E, Maher TM, Molyneaux PL, Protti R, Ravaglia C, Renzoni EA, Saito-Koyama R, Sverzellati N, Walsh SLF, Wolters P, Yang SR, Travis W, Nicholson A

doi: 10.1183/13993003.00158-2025

COMMENTED

Bronchi

European Respiratory Society Clinical Practice Guideline for the Management of Adult Bronchiectasis

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Eur Respir J

Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, Blasi F, Herrero-Cortina B, Dhar R, Chotirmall SH, Ringshausen FC, Altenburg J, Morgan L, Nigro M, Crichton ML, Van Meel C, Sibila O, Timothy A, Kompatsiari E, Hedberg T, Vandendriessche T, McShane PJ, Tonia T, Winthrop K, Loebinger MR, Lorent N, Goeminne P, Shteinberg M, Polverino E, Aliberti S

doi: 10.1183/13993003.01126-2025

Pneumonia

PneumoMLPred: Innovating Pneumonia Management with Guideline Adherence Review and Explainable Machine Learning-based Mortality Prediction - A single-centre retrospective study

Respir Med

Samara KA, Barqawi HJ, Adra S, Aldaher B, Kampani DD, Haddad E, Soudan H, Anwar II, Adi MB, Hamadi O, Almour Y, Nassef M, Al Aghbari Z, Abu Gharbieh E

doi: 10.1016/j.rmed.2026.108896

RECOMMENDED

COPDPneumonia

Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

Respir Med

Cazzola M, Maniscalco M, Patella V, Calzetta L, Matera MG, Rogliani P

doi: 10.1016/j.rmed.2025.108292

Pleural Diseases

ERS Statement on ultrasound guided interventions in respiratory disease

Eur Respir J

Hassan M, Addala D, Asciak R, Díez-Ferrer M, Fitzgerald D, Grabczak EM, Joyce V, Mangiapan G, Mei F, Panou V, Pieterson PI, Ricciardi S, Shafiek H, Jones E, Pavanello S, Harriss E, Cardillo G, Prosch H, Shojaee S, Laursen CB, Rahman NM

doi: 10.1183/13993003.01902-2025

COMMENTED

Asthma

Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 2 Recommended and commented by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Wechsler ME, Brightling CE, Brusselle G, Caminati M, Soler T, González EM, Nakwan N, Capala-Szczurko I, Hunter G, Almqvist G, Lal H, Kabelis P, Scrigner P, Matsunaga Y, Molfino N, Ponnarambil SS, SUNRISE study investigators

doi: 10.1016/S2213-2600(26)00076-7

Related content

Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline

The Long-term Pneumonia Mortality Index. An International Multicenter Derivation and Validation Study for Patients with Community-Acquired Pneumonia

Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline

Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement

European Respiratory Society Clinical Practice Guideline for the Management of Adult Bronchiectasis

PneumoMLPred: Innovating Pneumonia Management with Guideline Adherence Review and Explainable Machine Learning-based Mortality Prediction - A single-centre retrospective study

Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes

ERS Statement on ultrasound guided interventions in respiratory disease

Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial